MicroRNAs and their role in gynecological tumors (Q37722649)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 31 March 2010

Language	Label	Description	Also known as
English	MicroRNAs and their role in gynecological tumors	scientific article published on 31 March 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

1 reference

Europe PubMed Central

MicroRNAs and their role in gynecological tumors (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

1 reference

based on heuristic

inferred from title

2

object named as

Kamil Torres

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

1

object named as

Anna Torres

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Ryszard Maciejewski

3

object named as

Ryszard Maciejewski

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

author name string

William H Harvey

4

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

publication date

31 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Medicinal Research Reviews

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

895-923

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNAs: recently discovered key regulators of proliferation and apoptosis in animal cells : Identification of miRNAs regulating growth and survival

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Cell-cycle control of microRNA-mediated translation regulation

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNAs and cell cycle regulation

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Role of microRNAs in vascular diseases, inflammation, and angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

mir-29 regulates Mcl-1 protein expression and apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA and cancer--focus on apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNAs identified in highly purified liver-derived mitochondria may play a role in apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Epigenetic and microRNA-mediated regulation in diabetes

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNAs: role in cardiovascular biology and disease

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

The role of microRNAs in cancer: no small matter.

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

A microRNA expression signature of human solid tumors defines cancer gene targets

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

miRBase: tools for microRNA genomics

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Human MicroRNA targets

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNAs: genomics, biogenesis, mechanism, and function

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

The functions of animal microRNAs

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNAs: small RNAs with a big role in gene regulation

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA genes are transcribed by RNA polymerase II

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

RNA polymerase III transcribes human microRNAs

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Processing of intronic microRNAs

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA silencing through RISC recruitment of eIF6

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA-directed cleavage of HOXB8 mRNA

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Evidence that microRNAs are associated with translating messenger RNAs in human cells

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Human let-7a miRNA blocks protein production on actively translating polyribosomes

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNAs direct rapid deadenylation of mRNA

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA function: multiple mechanisms for a tiny RNA?

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Identification of novel genes coding for small expressed RNAs

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Profiling microRNA expression with microarrays

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Strategies for profiling microRNA expression

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Real-time quantification of microRNAs by stem-loop RT-PCR

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Real-time PCR quantification of precursor and mature microRNA.

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Reliable microRNA profiling in routinely processed formalin-fixed paraffin-embedded breast cancer specimens using fluorescence labelled bead technology

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

The colorectal microRNAome

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Detection of MicroRNAs using target-guided formation of conducting polymer nanowires in nanogaps

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Attomole microarray detection of microRNAs by nanoparticle-amplified SPR imaging measurements of surface polyadenylation reactions

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Detection of cancer with serum miRNAs on an oligonucleotide microarray

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Circulating microRNAs as stable blood-based markers for cancer detection

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Computational identification of microRNAs and their targets.

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

A microRNA polycistron as a potential human oncogene

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

microRNAs as oncogenes and tumor suppressors

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

RAS is regulated by the let-7 microRNA family

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

miR-15 and miR-16 induce apoptosis by targeting BCL2

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

microRNAs and cancer: role in tumorigenesis, patient classification and therapy.

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNAs accurately identify cancer tissue origin

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Cancer of the ovary

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA signatures in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA expression profiles in serous ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

microRNAs exhibit high frequency genomic alterations in human cancer

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA gene expression deregulation in human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Specific microRNAs are downregulated in human thyroid anaplastic carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA expression profiling in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Let-7 expression defines two differentiation stages of cancer

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA expression and identification of putative miRNA targets in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Sequence variations of microRNAs in human cancer: alterations in predicted secondary structure do not affect processing.

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors Are Associated With Distinctive Pathologic Features and Clinical Behavior

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

miR-29b expression is associated with disease-free survival in patients with ovarian serous carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Potential role of miR-9 and miR-223 in recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Improved survival in BRCA2 carriers with ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Role of microRNAs in drug-resistant ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

The Synergistic Effect of Conditional Pten Loss and Oncogenic K-ras Mutation on Endometrial Cancer Development Occurs via Decreased Progesterone Receptor Action

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women.

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Expression profile of mammalian microRNAs in endometrioid adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Expression profiling identifies microRNA signature in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Micro-RNA profiling in kidney and bladder cancers

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Proteomics reveals protein profile changes in cyclooxygenase-2 inhibitor-treated endometrial cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Co-expression of survivin, c-erbB2, and cyclooxygenase-2 (COX-2): prognostic value and survival of endometrial cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Characterization of the biological roles of the estrogen receptors, ERalpha and ERbeta, in estrogen target tissues in vivo through the use of an ERalpha-selective ligand

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Estrogen Regulation of MicroRNA Expression

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines.

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

The expression and ovarian steroid regulation of endometrial micro-RNAs

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Chapter 2: The burden of HPV-related cancers

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Persistence of high-grade cervical dysplasia and cervical cancer requires the continuous expression of the human papillomavirus type 16 E7 oncogene

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Patterns of known and novel small RNAs in human cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Downregulation of microRNAs-143 and -145 in B-cell malignancies

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Laminin-5 beta3A expression in LNCaP human prostate carcinoma cells increases cell migration and tumorigenicity

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Altered MicroRNA expression in cervical carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Changes in rates of hysterectomy and uterine conserving procedures for treatment of uterine leiomyoma

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Gene expression profiling of multiple leiomyomata uteri and matched normal tissue from a single patient

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

The expression and potential regulatory function of microRNAs in the pathogenesis of leiomyoma

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

RNASEN regulates cell proliferation and affects survival in esophageal cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Genetic analysis of cancer-implicated MicroRNA in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis.

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Rapid alteration of microRNA levels by histone deacetylase inhibition

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Extensive post-transcriptional regulation of microRNAs and its implications for cancer

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels.

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patients.

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Dicer, Drosha, and outcomes in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Reduced expression of Dicer associated with poor prognosis in lung cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Overexpression of Dicer in precursor lesions of lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Molecular therapy in the microRNA era.

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Specificity, duplex degradation and subcellular localization of antagomirs

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

The utility of LNA in microRNA-based cancer diagnostics and therapeutics

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease?

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Silencing of microRNAs in vivo with 'antagomirs'

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Sequence-specific inhibition of small RNA function

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Synthetic microRNA designed to target glioma-associated antigen 1 transcription factor inhibits division and induces late apoptosis in pancreatic tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Characterization of microRNA expression levels and their biological correlates in human cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Impaired microRNA processing enhances cellular transformation and tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA expression, survival, and response to interferon in liver cancer

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA Inhibition of Translation Initiation in Vitro by Targeting the Cap-Binding Complex eIF4F

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FMED.20205

21 January 2018

Identifiers

10.1002/MED.20205

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37722649&oldid=1725554189"